Camillo Autore

Pubblicazioni

Titolo Pubblicato in Anno
Insights from cardiopulmonary exercise testing in pediatric patients with hypertrophic cardiomyopathy BIOMOLECULES 2021
Insights from Cardiopulmonary Exercise Testing in Pediatric Patients with Hypertrophic Cardiomyopathy BIOMOLECULES 2021
Left Ventricular Remodeling in Hypertrophic Cardiomyopathy: An Overview of Current Knowledge JOURNAL OF CLINICAL MEDICINE 2021
The Many Faces of Arterial Hypertension in Hypertrophic Cardiomyopathy and Its Phenocopies: Bystander, Consequence, Modifier HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION 2021
Novel Imaging and Genetic Risk Markers in Takotsubo Syndrome FRONTIERS IN CARDIOVASCULAR MEDICINE 2021
Long-term management of Takotsubo syndrome: a not-so-benign condition REVIEWS IN CARDIOVASCULAR MEDICINE 2021
Common genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and expressivity NATURE GENETICS 2021
Reply to the letter “Takotsubo syndrome: Any more covariates of its recurrence?” INTERNATIONAL JOURNAL OF CARDIOLOGY 2021
Current patterns of beta-blocker prescription in cardiac amyloidosis. an Italian nationwide survey ESC HEART FAILURE 2021
Yield of bone scintigraphy screening for transthyretin-related cardiac amyloidosis in different conditions. Methodological issues and clinical implications EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 2021
Takotsubo syndrome. hyperthyroidism, pheochromocytoma, or both? A case report EUROPEAN HEART JOURNAL. CASE REPORTS 2021
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization-the first insight from the AC-TIVE Study EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY 2021
Implantable cardioverter-defibrillators for hypertrophic cardiomyopathy: The Times They Are a-Changin' EUROPACE 2021
Yield of bone scintigraphy screening for transthyretin-related cardiac amyloidosis in different conditions. Methodological issues and clinical implications EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 2021
Current patterns of beta-blocker prescription in cardiac amyloidosis. an Italian nationwide survey ESC HEART FAILURE 2021
Left ventricular remodeling in hypertrophic cardiomyopathy: an overview of current knowledge JOURNAL OF CLINICAL MEDICINE 2021
The Many Faces of Arterial Hypertension in Hypertrophic Cardiomyopathy and Its Phenocopies: Bystander, Consequence, Modifier HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION 2021
Arterial thrombo-embolic events in cardiac amyloidosis. a look beyond atrial fibrillation AMYLOID 2021
Risk stratification in hypertrophic cardiomyopathy. Insights from genetic analysis and cardiopulmonary exercise testing JOURNAL OF CLINICAL MEDICINE 2020
Low sensitivity of bone scintigraphy in detecting Phe64Leu mutation-related transthyretin cardiac amyloidosis JACC. CARDIOVASCULAR IMAGING 2020

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma